Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00951015
What this trial is testing

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 208
Early research (Phase 1)Study completedNCT05604209
What this trial is testing

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART

Who this might be right for
HIV VaccineHIV-1-infection
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT00000925
What this trial is testing

Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00854204
What this trial is testing

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

Who this might be right for
HIV-I
Tibotec Pharmaceuticals, Ireland 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05705349
What this trial is testing

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 537
Testing effectiveness (Phase 2)Study completedNCT05330143
What this trial is testing

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

Who this might be right for
HIV-1-infectionHIV InfectionsPD-L1 Gene Mutation
Ascletis Pharmaceuticals Co., Ltd. 19
Large-scale testing (Phase 3)UnknownNCT00006208
What this trial is testing

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00648817
What this trial is testing

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Who this might be right for
HIV Infections
Gilead Sciences 8
Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Not applicableLooking for participantsNCT07643948
What this trial is testing

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Who this might be right for
HIV -1 InfectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong 420
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableActive Not RecruitingNCT06358885
What this trial is testing

IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention

Who this might be right for
HIV-1-infectionUnhealthy Alcohol Use
University of North Carolina, Chapel Hill 3,234
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT00438152
What this trial is testing

Lopinavir Capsules to Kaletra or Invirase Tablets

Who this might be right for
HIV Infections
Royal Free Hampstead NHS Trust 53
Testing effectiveness (Phase 2)Study completedNCT00534352
What this trial is testing

Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Who this might be right for
HIV-1 Infection
Tibotec, Inc 23
Not applicableNot Yet RecruitingNCT07080138
What this trial is testing

Research on the Psychological Status of Patients With HIV-1 Infection

Who this might be right for
HIV-1-infectionAnxiety Depression
Shanxi Bethune Hospital 500
Early research (Phase 1)Looking for participantsNCT06517693
What this trial is testing

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 48
Post-approval studies (Phase 4)Study completedNCT00549198
What this trial is testing

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
GlaxoSmithKline 392
Next Page